Teclison Ltd.
Teclison Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer | Digestive System Diseases, Digestive System Neoplasms, Hypoxia, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2026-04-20 | NCT02174549 | |
| TATE and Pembrolizumab (MK3475) in mCRC and NSCLC | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-04-16 | NCT04701476 | |
| Combination of TATE and PD-1 Inhibitor in Liver Cancer | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Disease Progression, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gastric cancer, gastric neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, stomach disorder | Recruiting | Phase 2 | 2026-04-16 | NCT03259867 |